From Interest to Implementation: Building Sustainable LAI HIV Treatment & PrEP Programs
Studio AAs interest in long‑acting injectable (LAI) HIV treatment and PrEP continues to grow, many healthcare sites face real‑world challenges translating enthusiasm into sustainable programs. This peer‑to‑peer panel focuses on the practical “how” of LAI implementation, featuring external experts with hands‑on experience navigating operational workflows, site‑level decision‑making, and reimbursement considerations across medical benefit (buy‑and‑bill) and pharmacy benefit models.


